Cargando…

Correction: Temporal Dissection of K-ras(G12D) Mutant In Vitro and In Vivo Using a Regulatable K-ras(G12D) Mouse Allele

Detalles Bibliográficos
Autores principales:	Wang, Zuoyun, Feng, Yan, Bardessy, Nabeel, Wong, Kwok-Kin, Liu, Xin-Yuan, Ji, Hongbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394811/ http://dx.doi.org/10.1371/annotation/0671c124-a263-49e9-9c23-421fd125db2c

Ejemplares similares

Temporal Dissection of K-ras(G12D) Mutant In Vitro and In Vivo Using a Regulatable K-ras(G12D) Mouse Allele
por: Wang, Zuoyun, et al.
Publicado: (2012)

Oncogenic G12D mutation alters local conformations and dynamics of K-Ras
por: Vatansever, Sezen, et al.
Publicado: (2019)

Specific Activation of K-Ras(G12D) Allele in the Bladder Urothelium Results in Lung Alveolar and Vascular Defects
por: Ayala de la Peña, Francisco, et al.
Publicado: (2014)

Excited-state observation of active K-Ras reveals differential structural dynamics of wild-type versus oncogenic G12D and G12C mutants
por: Hansen, Alexandar L., et al.
Publicado: (2023)

Ppp6c deficiency accelerates K‐ras (G12D) ‐induced tongue carcinogenesis
por: Kishimoto, Kazuhiro, et al.
Publicado: (2021)

Effective Use of PI3K and MEK Inhibitors to Treat Mutant K-Ras G12D and PIK3CA H1047R Murine Lung Cancers
por: Engelman, Jeffrey A., et al.
Publicado: (2008)

(1)H, (15)N backbone assignment and comparative analysis of the wild type and G12C, G12D, G12V mutants of K-Ras bound to GDP at physiological pH
por: Pálfy, Gyula, et al.
Publicado: (2019)

In silico-guided sequence modifications of K-ras epitopes improve immunological outcome against G12V and G13D mutant KRAS antigens
por: Ng, Allan Wee Ren, et al.
Publicado: (2018)

The Role of Dlc1 Isoform 2 in K-Ras2(G12D) Induced Thymic Cancer
por: Sabbir, Mohammad Golam, et al.
Publicado: (2012)

Comparative effects of oncogenic mutations G12C, G12V, G13D, and Q61H on local conformations and dynamics of K-Ras
por: Vatansever, Sezen, et al.
Publicado: (2020)

Chemical acylation of an acquired serine suppresses oncogenic signaling of K-Ras(G12S)
por: Zhang, Ziyang, et al.
Publicado: (2022)

Loss of protein phosphatase 6 in mouse keratinocytes enhances K‐ras (G12D)‐driven tumor promotion
por: Kurosawa, Koreyuki, et al.
Publicado: (2018)

GTP-State-Selective Cyclic Peptide Ligands of K-Ras(G12D) Block Its Interaction with Raf
por: Zhang, Ziyang, et al.
Publicado: (2020)

Establishment and Characterization of Immortalized Miniature Pig Pancreatic Cell Lines Expressing Oncogenic K-Ras(G12D)
por: Yang, Hae-Jun, et al.
Publicado: (2020)

Lactobacillus Attenuate the Progression of Pancreatic Cancer Promoted by Porphyromonas Gingivalis in K-ras(G12D) Transgenic Mice
por: Chen, Shan-Ming, et al.
Publicado: (2020)

The Distinct Conformational Dynamics of K-Ras and H-Ras A59G
por: Lukman, Suryani, et al.
Publicado: (2010)

Increased frequency of the k-ras G12C mutation in MYH polyposis colorectal adenomas
por: Jones, S, et al.
Publicado: (2004)

Chemoselective Covalent Modification of K-Ras(G12R) with a Small Molecule Electrophile
por: Zhang, Ziyang, et al.
Publicado: (2022)

In Silico Strategies for Designing of Peptide Inhibitors of Oncogenic K-Ras G12V Mutant: Inhibiting Cancer Growth and Proliferation
por: Ghufran, Mehreen, et al.
Publicado: (2022)

Activating the Expression of Human K-ras(G12D) Stimulates Oncogenic Transformation in Transgenic Goat Fetal Fibroblast Cells
por: Gong, Jianhua, et al.
Publicado: (2014)

Generation of KS-58 as the first K-Ras(G12D)-inhibitory peptide presenting anti-cancer activity in vivo
por: Sakamoto, Kotaro, et al.
Publicado: (2020)

Loss of Aryl Hydrocarbon Receptor Favors K-Ras(G12D)-Driven Non-Small Cell Lung Cancer
por: Nacarino-Palma, Ana, et al.
Publicado: (2021)

Nanoformulation of the K-Ras(G12D)-inhibitory peptide KS-58 suppresses colorectal and pancreatic cancer-derived tumors
por: Sakamoto, Kotaro, et al.
Publicado: (2023)

The Structural Basis of Oncogenic Mutations G12, G13 and Q61 in Small GTPase K-Ras4B
por: Lu, Shaoyong, et al.
Publicado: (2016)

Mutant K-Ras in Pancreatic Cancer: An Insight on the Role of Wild-Type N-Ras and K-Ras-Dependent Cell Cycle Regulation
por: Ferguson, Robert, et al.
Publicado: (2023)

Direct Ras G12C inhibitors: crossing the rubicon
por: Lindsay, Colin R., et al.
Publicado: (2019)

K-Ras Peptide Mimotope Induces Antigen Specific Th1 and B-Cell Immune Responses against G12A-Mutated K-Ras Antigen in Balb/c Mice
por: Siak, Pui Yan, et al.
Publicado: (2021)

The K-Ras(G12D)-inhibitory peptide KS-58 suppresses growth of murine CT26 colorectal cancer cell-derived tumors
por: Sakamoto, Kotaro, et al.
Publicado: (2022)

Investigation of GTP-dependent dimerization of G12X K-Ras variants using ultraviolet photodissociation mass spectrometry
por: Mehaffey, M. Rachel, et al.
Publicado: (2019)

K-ras oncogene codon 12 point mutations in testicular cancer.
por: Ridanpää, M, et al.
Publicado: (1993)

Feedback activation of EGFR/wild-type RAS signaling axis limits KRAS(G12D) inhibitor efficacy in KRAS(G12D)-mutated colorectal cancer
por: Feng, Juanjuan, et al.
Publicado: (2023)

Suppression of mutant Kirsten-RAS (KRAS(G12D))-driven pancreatic carcinogenesis by dual-specificity MAP kinase phosphatases 5 and 6
por: Kidger, Andrew M., et al.
Publicado: (2022)

Catalytically Competent Non-transforming H-RAS(G12P) Mutant Provides Insight into Molecular Switch Function and GAP-independent GTPase Activity of RAS
por: Ilter, Metehan, et al.
Publicado: (2019)

Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP
por: McFall, Thomas, et al.
Publicado: (2022)

Inhibition of colon cancer K-Ras(G13D) mutation reduces cancer cell proliferation but promotes stemness and inflammation via RAS/ERK pathway
por: Qi, Yan, et al.
Publicado: (2022)

Killer K-Ras
por: Powell, Kendall
Publicado: (2006)

K-RAS Is…Complicated
por: Clark, Geoffrey J.
Publicado: (2023)

Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression
por: Jin, Hua, et al.
Publicado: (2019)

Comparative Analysis of Radiosensitizers for K-RAS Mutant Rectal Cancers
por: Kleiman, Laura B., et al.
Publicado: (2013)

A covalent inhibitor of K-Ras(G12C) induces MHC-I presentation of haptenated peptide neoepitopes targetable by immunotherapy
por: Zhang, Ziyang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_icln71g3akmn6hur28ath01eo4